← Eichor
Condition: Edema Secondary Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Edema Secondary

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · 56 location(s) · Kodiak Sciences Inc · NCT06996080A Dose-finding Study of JMKX003142 in Treatment of Renal Edema
Phase 2 · 2 location(s) · Jemincare · NCT06670534A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary
Phase 3 · 56 location(s) · Kodiak Sciences Inc · NCT06990399A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
Phase 1 · 7 location(s) · Therini Bio Pty Ltd · NCT06701721Prospective Cohort Study of Intracerebral Hemorrhage
Phase N/A · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04707105Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema
Phase 2 · 1 location(s) · Peter Siesjö · NCT06710249TaVNS for Acute Intracerebral Hemorrhage
NA · 1 location(s) · Beijing Tiantan Hospital · NCT06918964Screening For BCRL In Targeted Therapy For Breast Cancer
Phase N/A · 1 location(s) · Massachusetts General Hospital · NCT05142800AURN001 Efficacy in Participants With Corneal Edema Secondary to Corneal Endothelial Dysfunction
Phase 3 · 12 location(s) · Aurion Biotech · NCT07368959
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.